Could a seizure drug cream fix receding gums?
NCT ID NCT07590375
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a cream made from phenytoin, a seizure drug known to cause gum overgrowth, can help receding gums grow back. Thirty adults who want to avoid surgery will apply either the phenytoin cream or a placebo paste. Researchers will measure changes in gum attachment and thickness over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- phenytoin cream
- What this could lead to
- If it works, this could offer a non-surgical option to treat gum recession, potentially avoiding the need for invasive gum grafts.
- What could go wrong
- This is a small, early-phase trial with only 30 people. Phenytoin's effect on gums is known from a side effect, but it may not work for everyone or could cause irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients having gingival recession types RT1 and RT2 * Patients refusing surgical treatment options of their gingival recession. Exclusion Criteria: * Patients who underwent periodontal surgery in the affected teeth. * Patients with sensitivity to the medication used in the study. * Patients with systemic problems or administering drugs which could affect their periodontium or healing. * Pregnant or lactating women. * Smoking patients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gingival recession are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gum graft surgery: does the bed matter for thin gums?
- Boosting gum grafts: do blood or gel Add-Ons reduce shrinkage?
- Can a new flap technique better cover receding gums?
- A new twist on gum surgery could better cover exposed roots
- Gum graft boost: growth factors may strengthen receding gum repair
- Micro-needling vs. gum graft: a tiny trial tests a simpler fix for receding gums